Dr H Rogier van Doorn


Dr H Rogier van Doorn, MD PhD.

MD – Consultant Clinical Microbiology and Virology, University of Amsterdam (NL), Faculty of Medicine, 1990-1998 2003-2007. Registrations: RIBIZ (NL) 69052473801, GMC (UK) 6168758.

PhD – University of Amsterdam (NL), Faculty of Medicine, Academic Medical Centre, Department of Medical Microbiology, 1999-2005.


Director of OUCRU Ha Noi


Rogier is a Clinical Microbiologist from the Netherlands who has worked at OUCRU since the end of 2007. In his role as head of the virology lab for the Southeast Asian Infectious Disease Clinical Research Network he has led analysis of several diagnostic and intervention studies on human influenza, developed diagnostic lab capacity in local hospitals and BSL3/SAPO4 facility at OUCRU. As head of the Emerging Infections group he has worked on diagnostics and clinical research of emerging infections, led a multifaceted research program on Hand, Foot and Mouth Disease, and projects on pathogen discovery.

Currently, Rogier leads the OUCRU Ha Noi unit with research focus on antimicrobial resistance and influenza and other respiratory infections.


Rogier has published more than 50 articles in international peer-reviewed journals, 36 affiliated with OUCRU.

Key PubMED indexed publications:

Hien TT, Boni MF, Bryant JE, Ngan TT, Wolbers M, Nguyen DT, Truong TT, Dung NT, Ha DQ, Hien VM, Thanh TT, Nhu LNT, Uyen LTT, Nhien PT, Chinh NT, Chau NVV, Farrar J, van Doorn H R. Early pandemic influenza (2009H1N1) in Ho Chi Minh City, Vietnam: a clinical virological and epidemiological analysis. PLoS Med. 2010; 7(5):e1000277. PMID: 20502525

van Doorn HR, Kinh NV, Tuan HM, Tuan TA, Minh NNQ, Bryant JE, et al. Clinical validation of a point-of-care multiplexed in vitro immunoassay using monoclonal antibodies (MSD® Influenza Test) in 4 hospitals in Vietnam. J Clin Microbiol. 2012; 50(5):1621-5. PMID: 22357497

TH Khanh, Sabanathan S, Thanh TT, Thoa LPK, Thuong TC, Hang VTT, Farrar J, Hien TT, Chau NVV, van Doorn HR. Enterovirus 71 associated Hand, Foot and Mouth Disease, southern Vietnam, 2011. CME activity. Emerg Infect Dis. 2012; 18(12):2002-5. PMID: 23194699

SEAICRN. Effect of double dose oseltamivir on clinical and virological outcomes in children and adults admitted to hospital with severe influenza: double blind randomised controlled trial. Br Med J. 2013; 346:f3039. PMID: 23723457

Tan LV, van Doorn HR, Nghia HDT, Chau TTH, Tu LTP,  de Vries M, et al. Identification of a new cyclovirus in cerebrospinal fluid of patients with acute central nervous system infections. mBio. 2013. 4(3):e00231-13. PMID: 23781068


Key publications – books/monographs etc:

van Doorn HR,  Yu H. Chapter 29: Viral respiratory infections, pp 269-274. In: Hunter’s Tropical Medicine and Emerging infectious Diseases. 9th ed. Oxford: Elsevier; 2012. ISBN: 978-1-4160-4390-4.

McNamara PS,  van Doorn HR. Respiratory viruses and atypical bacteria. In: Manson’s Tropical Diseases. 23rd ed. London: W. B. Saunders Ltd; 2013.

van Doorn HR. Pathogen discovery in the respiratory tract. In: Gillespie S, editor. Respiratory infection, the biomedical & life sciences collection. London: Henry Stewart Talks Ltd; 2013. (online at http://hstalks.com/?t=BL1573465-vanDoorn)

van Doorn HR. Emerging Infectious Diseases. Medicine. 2013. Review.


Dr van Doorn’s Google scholar Profile.